Dr Chahoud on the Safety of ALLO-316 in Advanced ccRCC - OncLive
17 hours ago • Google News
Allogene Therapeutics, Inc. a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer and autoimmune diseases.
17 hours ago • Google News
2025-05-05 • Google News
3 weeks ago • Google News